tirofiban has been researched along with Brain Emboli in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, YL; Du, B; Du, J; Duan, WB; Kong, XK; Lin, T; Liu, L; Wen, WL; Wu, Z; Yu, YJ | 1 |
| Chen, J; Feng, L; Liu, J; Lv, CF | 1 |
| Cho, YD; Han, MH; Jung, KH; Kang, HS; Kim, JE; Lee, JY; Seo, JH | 1 |
| Junghans, U; Siebler, M | 1 |
| Higman, DJ; Imray, CH; Jarvi, K; Marshall, C; Tiivas, CA; van Dellen, D | 1 |
2 trial(s) available for tirofiban and Brain Emboli
| Article | Year |
|---|---|
Intra-arterial tirofiban infusion for thromboembolic complication during coil embolization of ruptured intracranial aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Comorbidity; Embolization, Therapeutic; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Intracranial Aneurysm; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Prevalence; Radiography; Republic of Korea; Tirofiban; Treatment Outcome; Tyrosine | 2012 |
Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Clopidogrel; Female; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2003 |
3 other study(ies) available for tirofiban and Brain Emboli
| Article | Year |
|---|---|
[Safety and efficacy of intra-arterial tirofiban infusion in patients with acute cardiogenic cerebral embolism undergoing endovascular reperfusion therapy].
Topics: Humans; Intracranial Embolism; Reperfusion; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome | 2022 |
Intra-arterial infusion of tirofiban and urokinase for thromboembolic complications during coil embolization of ruptured intracranial aneurysms.
Topics: Adult; Aged; Aneurysm, Ruptured; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Intracranial Embolism; Intracranial Thrombosis; Male; Mechanical Thrombolysis; Middle Aged; Subarachnoid Hemorrhage; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2014 |
Transcranial Doppler ultrasonography-directed intravenous glycoprotein IIb/IIIa receptor antagonist therapy to control transient cerebral microemboli before and after carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Combined Modality Therapy; Endarterectomy, Carotid; Female; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Postoperative Complications; Preoperative Care; Tirofiban; Tyrosine; Ultrasonography, Doppler, Transcranial; Ultrasonography, Interventional | 2008 |